Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Northern Africa

Northern Africa

In 2024, the Digestives & Intestinal Remedies market market in Northern Africa is projected to generate a revenue of US$0.31bn.
It is anticipated that the market will experience an annual growth rate of 7.26% (CAGR 2024-2029).
When compared globally, in China dominates the market, generating a substantial revenue of US$4,408.00m in 2024.
On a per capita basis, the revenue generated amounts to US$1.20.
In Northern Africa, there is a growing demand for natural and herbal digestive remedies in the OTC Pharmaceuticals market.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in Northern Africa is experiencing significant growth and development due to several key factors. Customer preferences in the Digestives & Intestinal Remedies market in Northern Africa are shifting towards natural and herbal remedies. Consumers are becoming more conscious about their health and are seeking products that are perceived as safer and more gentle on the body. This preference for natural remedies is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for herbal supplements and traditional remedies in the Digestives & Intestinal Remedies market.Trends in the Digestives & Intestinal Remedies market in Northern Africa include the increasing popularity of probiotics and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for digestive health, while digestive enzymes help break down food and improve digestion. These products are gaining traction among consumers who are looking for solutions to common digestive issues such as bloating, indigestion, and irregular bowel movements. The growing interest in probiotics and digestive enzymes can be attributed to the increasing awareness of gut health and its impact on overall well-being.Local special circumstances in Northern Africa also contribute to the development of the Digestives & Intestinal Remedies market. The region has a rich tradition of herbal medicine, with many indigenous plants and herbs being used for centuries to treat digestive ailments. This cultural heritage has created a strong market for traditional remedies and herbal supplements. Additionally, the prevalence of certain digestive disorders, such as irritable bowel syndrome and acid reflux, in the region further drives the demand for Digestives & Intestinal Remedies.Underlying macroeconomic factors, such as population growth and increasing disposable income, also play a role in the development of the Digestives & Intestinal Remedies market in Northern Africa. As the population continues to grow, there is a larger consumer base for healthcare products, including Digestives & Intestinal Remedies. Rising disposable income levels enable consumers to afford these products, further fueling market growth. Additionally, urbanization and changing lifestyles contribute to an increased demand for Digestives & Intestinal Remedies, as urban dwellers are more likely to experience digestive issues due to factors such as stress, sedentary lifestyles, and unhealthy diets.Overall, the Digestives & Intestinal Remedies market in Northern Africa is experiencing growth and development driven by customer preferences for natural remedies, trends towards probiotics and digestive enzymes, local cultural practices, and underlying macroeconomic factors. As consumers become more health-conscious and seek alternative solutions for digestive issues, the market is expected to continue expanding in the coming years.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.